The Marketing Research Of Chinese Pharmaceutical Corporations

With the processing of the Chinese new medicine reforms of China, and the further participating from oversee competitor in the times after WTO, There are significantly change in the POMS industry for Chinese pharmaceutical corporations, whatever inside and outside the industrial environment. The new role maybe come into the value chain of POMS consumption, and moreover effect of each roles appeared on the chain also is renewed to fix position and distribute. The campaign of Chinese pharmaceutical corporations in POMS marketing is confronted with new opportunities and challenges. Therefore it is essential to advise Chinese pharmaceutical corporations making adjustment corresponding the direction and suggestion through systematic analysis on the industry and the market.POMS for most people, do not pay a greater extent depend on third-party-a doctor's preference, which is led by doctors to determine the use of drugs. r Drug information asymmetries exist between doctors and pharmaceutical consume. However, because of new medical reform the separation requirements, and accelerated the information age, this information asymmetry will be broken. POMS spending in the value chain initiator (patients) will have many medical and medical information access, new medical reform called for the establishment of pharmacies licensed pharmacists, medical insurance, prescription drug spending to join the economic impact of those National Essential Drug audit specialists will be spending most of the major decision makers of prescription drugs, medical insurance will also be a prescription drug consumption in patients with major buyers. Prescription drug consumption value chain, a role has been or will soon launch a major change, and the role of the relationship between the respective roles and the concomitant reorientation, redistribution. Chinese relations, physician-patient relationship, drug patient relationship through research, analysis, predict the major changes will occur. "To prescribers centric" marketing of prescription drugs has been demonstrated Paradox touch with the new situation.On this basis, the National Pharmaceutical Industry Prescription Drug Marketing 4P framework should be based on the product marketing strategy to achieve echelon of product structure, to face the high-end, midrange, low-end three different levels of market demand, strengthen the development of traditional Chinese medicines to highlight Product differentiation; to implement target market channel strategy and channel re-re-engineering, effective marketing of prescription drugs to develop third side; in marketing strategies to the doctor's "pushing" type and the patient's "pull" marketing integration and find out some types of non-prescription drugs prescription drug promotion model; price strategy for new drugs. List of drugs and general medical insurance products to different pricing strategies should meet the development requirements of the new situation. At the same time, marketing organization to pharmaceutical companies in China, relationship marketing, the "vertical and horizontal" cross-borrowing advantage industries and enterprises for the greater good; knowledge of marketing in the education of doctors, simultaneous implementation of patient education marketing, and to physical education, marketing, interactive, innovative technology; experience in marketing prescription drugs create alternatives, doctors and patient experience of the delivered value of large amount spread; light of the current tide of the new drug research and development division of labor, academic promotion of the implementation of marketing outsourcing, making Chinese Pharmaceutical Enterprises. POMS Marketing to adapt to the new development and changes in implementation, industry, business to sustainable and healthy development.